Alterity Therapeutics Limited announced the appointment of Phillip Hains as the Company's new Chief Financial Officer (CFO), effective 31 January 2024. Mr. Hains has served as the Company Secretary of Alterity since 2014, and his experience includes almost 30 years in corporate secretarial, accounting and general management through professional services firm Acclime and predecessor firm The CFO Solution. The appointment of Mr. Hains follows the resignation of Kathryn Andrews, who has been CFO since 2014.

Ms. Andrews has chosen to leave Alterity to pursue other interests and will continue to support the Company during the transition.